| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
2,121 | 2,038 | 0 | 0 | 0 |
| Cost of Revenue
|
-12,611 | -9,702 | 0 | -- | -- |
|
Gross Profit
|
-10,490 | -7,664 | 0 | -- | -- |
| Selling, General and Administrative Expenses
|
-31,183 | -31,171 | -25,799 | -23,497 | -22,883 |
|
Research and Development Expenses
|
-69,484 | -69,302 | -88,599 | -76,550 | -63,260 |
| Other Income/Expense, Operating
|
-- | -- | -- | 0 | 1,565 |
|
Operating Income/Expenses
|
-100,667 | -100,473 | -114,398 | -100,047 | -84,578 |
|
Total Operating Profit/Loss
|
-111,157 | -108,137 | -114,398 | -100,047 | -84,578 |
| Total Net Finance Income/Expense
|
-8,486 | -8,663 | -5,173 | -1,132 | -3,571 |
| Net Investment Income
|
27,953 | 38,765 | 3,915 | -260 | 417 |
| Irregular Income/Expenses
|
-5,045 | 37,202 | -33,045 | -9,337 | 75,767 |
|
Non-Operating Income/Expenses, Total
|
14,422 | 67,304 | -34,303 | -10,729 | 72,613 |
|
Pretax Income
|
-96,735 | -40,833 | -148,701 | -110,776 | -11,965 |
|
Net Income from Continuing Operations
|
-96,735 | -40,833 | -148,701 | -110,776 | -11,965 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
-96,735 | -40,833 | -148,701 | -110,776 | -11,965 |
|
Net Income after Non-Controlling/Minority Interests
|
-96,735 | -40,833 | -148,701 | -110,776 | -11,965 |
| Preferred/Other Stock Distribution
|
0 | -- | -- | -- | -- |
|
Net Income Available to Common Stockholders
|
-96,735 | -40,833 | -148,701 | -110,776 | -11,965 |
|
Diluted Net Income Available to Common Stockholders
|
-96,735 | -40,833 | -148,701 | -110,776 | -11,965 |
| Basic EPS
|
-0.51 | -0.26 | -1.26 | -1.07 | -0.12 |
| Diluted EPS
|
-0.51 | -0.26 | -1.26 | -1.07 | -0.12 |
|
Basic Weighted Average Shares Outstanding
|
194,451.3170 | 158,160.4680 | 118,479.0970 | 103,420.2380 | 103,051.3660 |
|
Diluted Weighted Average Shares Outstanding
|
194,451.3170 | 158,160.4680 | 118,479.0970 | 103,420.2380 | 103,051.3660 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
-88,249 | -32,170 | -143,528 | -109,644 | -8,394 |
|
EBITDA
|
-81,020 | -24,825 | -136,338 | -103,944 | -2,194 |
|
Normalized EBITDA
|
-93,219 | -91,034 | -101,067 | -87,501 | -72,188 |
|
Normalized Income
|
-108,934 | -107,042 | -113,430 | -94,333 | -81,959 |
|
Total Unusual Items
|
-12,199 | -66,209 | 35,271 | 16,443 | -69,994 |
|
Total Unusual Items Excluding Goodwill
|
-12,199 | -66,209 | 35,271 | 16,443 | -69,994 |
12/31/2022 - 12/1/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade